Product Information
CHOLESTYRAMINE PACKET is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.7724 per EA under NDC 27241013436. Its NADAC has been published 277 times since Feb 10, 2021.
FDA first approved this application on Apr 6, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 g/9g
Manufacturer
Ajanta Pharma USA Inc.NDC
27241013436
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CHOLESTYRAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA211119FDA Approved
4/6/2020
TE Code
AB
On Market Since
4/6/2020
Pharmacological Classes
Price Statistics
The NADAC for CHOLESTYRAMINE PACKET has been published 277 times since Feb 10, 2021, and over the history we have for it it has declined 38.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7724 per EA |
|---|---|
| All-time high | $1.2770 (Sep 15, 2021) |
| All-time low | $0.5806 (Apr 17, 2024) |
| 52-week high | $0.9390 |
| 52-week low | $0.6721 |
| Median price | $0.9285 |
| Average price | $0.9396 |
| Largest weekly change | +34.2% (Jun 19, 2024) |
| Weeks tracked | 277 |
| Tracking since | Feb 10, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CHOLESTYRAMINE PACKET?
The current National Average Drug Acquisition Cost (NADAC) for CHOLESTYRAMINE PACKET, manufactured by Ajanta Pharma USA Inc., is $0.7724 per EA (NDC 27241013436), effective Aug 19, 2026.
How has the price of CHOLESTYRAMINE PACKET changed over time?
Over the history we have for it, the NADAC for CHOLESTYRAMINE PACKET has declined 38.9%. It has been tracked across 277 weekly CMS publications since Feb 10, 2021.
What are the highest and lowest recorded NADAC prices for CHOLESTYRAMINE PACKET?
Since Feb 10, 2021, the NADAC for CHOLESTYRAMINE PACKET has ranged from a low of $0.5806 (Apr 17, 2024) to a high of $1.2770 (Sep 15, 2021), with a median of $0.9285 per EA.
Are there cheaper alternatives to CHOLESTYRAMINE PACKET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHOLESTYRAMINE PACKET, is $0.6370 per EA — about 18% below CHOLESTYRAMINE PACKET.
Who manufactures CHOLESTYRAMINE PACKET?
CHOLESTYRAMINE PACKET (NDC 27241013436) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.